Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Apollo Future Technology Inc. d/b/a Apollo E Cigs
WARNING LETTER
•Apollo Future Technology Inc. d/b/a Apollo E Cigs•March 10, 2020

FDA WARNING_LETTER - Apollo Future Technology Inc. d/b/a Apollo E Cigs - March 10, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA Center for Tobacco Products reviewed apolloecigs.com and found that Electronic Nicotine Delivery System (ENDS) products, specifically BREZ Deluxe Pod Kit (containing Berry Blend and Melon Pods) and BREZ Pods 4-Pack Melon, are manufactured and sold in the U.S. These products are deemed "new tobacco products" under section 910(a) of the FD&C Act because they were not commercially marketed before February 15, 2007.

The identified ENDS products lack the required FDA marketing authorization order under section 910(c)(1)(A)(i) of the FD&C Act, making them adulterated under section 902(6)(A) and misbranded under section 903(a)(6). The failure to provide a required report under section 905(j) is also a prohibited act under section 301(p).

The company must ensure all tobacco products, labeling, and advertising comply with the FD&C Act and FDA regulations. Failure to correct these violations may lead to civil money penalties, seizure, and/or injunction. A written response detailing corrective actions, including discontinuation of violative sales and a compliance plan, is required within 15 working days.

Company
Apollo Future Technology Inc. d/b/a Apollo E Cigs
Inspection Date
March 10, 2020
Product Type
Tobacco
Office
Center for Tobacco Products
People
  • Ann Simoneau (Director)
  • Weihe Zhu
Open in Dashboard

ID · 222b2d30-e35a-496f-a27f-d177f9563cdb

Violation Codes9
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 CFR 1100.121 U.S.C. 387j(a)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387e(j)(3)21 U.S.C. 331(p)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.